Literature DB >> 10634450

Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis.

M A Lee1, A M Blamire, S Pendlebury, K H Ho, K R Mills, P Styles, J Palace, P M Matthews.   

Abstract

OBJECTIVE: To test the hypothesis that axonal damage extending into primarily normal-appearing white matter is clinically important by comparing the concentrations of N-acetylaspartate (NAA) bilaterally within the internal capsule with lateralization of motor impairment in patients with multiple sclerosis (MS) and persistent asymmetrical motor deficit.
DESIGN: We performed magnetic resonance spectroscopy and T2-weighted imaging of the internal capsule, calculated central motor conduction times, and related these results to measures of motor function asymmetry in 12 patients with MS.
RESULTS: Levels of NAA from normal-appearing white matter of the internal capsule in patients with MS were significantly lower than those in control subjects (P = .05). Side-to-side differences in NAA levels were also significantly greater in patients with MS than in controls (P = .01). There was a correlation between asymmetry in motor function for the left and right limbs and asymmetry of internal capsule NAA concentrations (r = 0.60; P = .04). This correlation seemed slightly stronger when tests specifically of arm and hand motor asymmetry were considered alone. Central motor conduction times were abnormal in most patients with MS and showed a side-to-side difference that also correlated with asymmetry in motor function.
CONCLUSION: Our demonstration of a graded association between NAA concentrations within primarily normal-appearing white matter of a specific tract and functional impairments referable to that tract suggests that axonal pathology distant from macroscopic lesions might be an important determinant of disability in MS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10634450     DOI: 10.1001/archneur.57.1.65

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  24 in total

Review 1.  Clinical trials and clinical practice in multiple sclerosis: conventional and emerging magnetic resonance imaging technologies.

Authors:  Massimo Filippi; Maria A Rocca; Marco Rovaris
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

2.  Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS.

Authors:  Bertrand Audoin; Danielle Ibarrola; Jean-Philippe Ranjeva; Sylviane Confort-Gouny; Irina Malikova; André Ali-Chérif; Jean Pelletier; Patrick Cozzone
Journal:  Hum Brain Mapp       Date:  2003-10       Impact factor: 5.038

3.  MR spectroscopy of cervical spinal cord in patients with multiple sclerosis.

Authors:  Ayşe Tuba Karagülle Kendi; Funda Uysal Tan; Mustafa Kendi; Sevda Yilmaz; Sinef Huvaj; Serdar Tellioğlu
Journal:  Neuroradiology       Date:  2004-09       Impact factor: 2.804

Review 4.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

5.  Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis.

Authors:  Daniel S Reich; Seth A Smith; Kathleen M Zackowski; Eliza M Gordon-Lipkin; Craig K Jones; Jonathan A D Farrell; Susumu Mori; Peter C M van Zijl; Peter A Calabresi
Journal:  Neuroimage       Date:  2007-08-15       Impact factor: 6.556

6.  Chronic cocaine administration causes extensive white matter damage in brain: diffusion tensor imaging and immunohistochemistry studies.

Authors:  Ponnada A Narayana; Juan J Herrera; Kurt H Bockhorst; Emilio Esparza-Coss; Ying Xia; Joel L Steinberg; F Gerard Moeller
Journal:  Psychiatry Res       Date:  2014-01-23       Impact factor: 3.222

7.  Disentangling the effects of early caregiving experience and heritable factors on brain white matter development in rhesus monkeys.

Authors:  Brittany R Howell; Mihye Ahn; Yundi Shi; Jodi R Godfrey; Xiaoping Hu; Hongtu Zhu; Martin Styner; Mar M Sanchez
Journal:  Neuroimage       Date:  2019-04-09       Impact factor: 6.556

Review 8.  White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.

Authors:  Melissa Cambron; Miguel D'Haeseleer; Guy Laureys; Ralph Clinckers; Jan Debruyne; Jacques De Keyser
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

9.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.

Authors:  Xin Zhang; Nazanin Kiapour; Sahil Kapoor; Joseph R Merrill; Yongjuan Xia; Woomi Ban; Stephanie M Cohen; Bentley R Midkiff; Valerie Jewells; Yen-Yu I Shih; Silva Markovic-Plese
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.